Trial intelligence / Profile preview

Pediatric dose-ranging trial of Zemuron for intubation during general anesthesia

2005-002928-34Phase 3Completed

Sponsor
Organon & Co.
Start
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of rocuronium (3 arms), sponsored by Organon & Co. Primary endpoint: Time to reappearance of T3. Started Nov 2005; status: completed.

02

Drugs

rocuronium

Beyond the preview

Go deeper on 2005-002928-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002928-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call